Since 29th April 2026, the President of Healthcare Poland Foundation, Mr. Michał P. Dybowski, has been on a working visit in the State of Israel, including at Assuta Medical Centers in Tel Aviv. Yesterdays visit forms part of the Foundation’s ongoing work in the development of Polish-Israeli cooperation in healthcare, and contributes to the implementation of the functional mandate institutionally supported by the Ministry of Health of the Republic of Poland in the medical tourism field.
Purpose of the visit
The visit of the HCPL President is strategic and operational in nature. Its main objectives include:
- deepening the dialogue with the Israeli private hospital ecosystem in the area of care for Polish patients for whom domestic therapeutic pathways are unavailable;
- review of operational models in precision oncology, radioisotope therapies (including Lutetium-177 PSMA), robotic surgery, and protocols applied in Israel beyond the standard European pathway;
- analysis of competency transfer mechanisms — those that can be permanently embedded in the Polish healthcare system rather than delivered as one-off interventions;
- discussions with Israeli partners on reference “innovation clinic” models, including the Assuta reference model as a benchmark for Polish-Swiss and Polish-Israeli initiatives.
Assuta Medical Centers — institutional partner
Assuta Medical Centers is the largest private hospital network in Israel, holding JCI accreditation and operating centers of excellence in oncology, cardiac surgery, robotic surgery, transplantation, and reproductive medicine. In the Polish context, Assuta has for years remained one of the most frequently chosen Israeli centers by Polish patients. Cooperation with Assuta has, for HCPL, both an operational dimension — patient access pathways — and a strategic one, as part of the broader concept of building healthcare corridors between Poland, Israel, and other European countries.
Polish-Israeli healthcare cooperation — a systemic perspective
HCPL’s activities in the Polish-Israeli area rest on three pillars:
- patient access — structured pathways for Polish patients to therapies unavailable in Poland, in compliance with GDPR (under European Commission Adequacy Decision 2011/61/EU for Israel), Polish patient rights, and coordination mechanisms with the Patient Rights Ombudsman;
- competency transfer — clinical fellowships of Polish physicians at Israeli centers, joint clinical trials, scientific publications, and joint postgraduate education;
- institutional architecture — contractual frameworks, patient protection mechanisms, patron and brand identity governance, and coordination with Polish public bodies.
The current visit of the HCPL President is a continuation of a broader institutional mission of the Foundation in Israel, conducted in recent weeks under the working name Insight Israel. The mission has included a series of meetings with Israeli medical centers, regulators, and academic partners. A comprehensive summary of the mission — including the announcement of specific cooperation outcomes — will be presented in the coming days on the Foundation’s official channels.
Institutional framework
HCPL’s activities in international healthcare cooperation align with the Foundation’s functional mandate, covering: advancement of the international visibility of Polish medicine; digital transformation of healthcare; patient-centered care and therapy safety; development of medical tourism and health-related service exports; and coordination of educational, regulatory, and scientific initiatives with national and international partners.
Further information on the progress of the visit and the broader Israeli mission of HCPL will be published on an ongoing basis.
Contact: global@healthcarepoland.pl LinkedIn: https://www.linkedin.com/company/healthcarepoland
